Drug Patents Under Fire in Brazil Brazil’s infamously overloaded patent system has undergone a series of recent reforms. One such “reform,” however, greatly complicates biopharmaceutical patent practice, write Ryan O’ Quinn and Sanya Sukduang ...Read more
Value-Based Pricing in the UK: Will Scotland Take a Different Approach? Value-based pricing (VBP) continues to confuse many in the UK and further afield. The Scottish Parliament’s Health and Sport Committee is the latest parliamentary committee to question civil servants about what it’s all about. Leela Barham outlines the key take-aways ... Read more
Europe Faces Persistent Gaps in International GCP Inspections One of the most striking finds of the report just released by the European Medicines Agency on clinical trials conducted beyond Europe is the number of trial sites – and how few of them are inspected., writes Peter O' Donnell ... Read more
The New Commercial Model Myth Pharma professionals need to find new competitive — not commercial — models to succeed in the competitive stage of the industry's lifecycle, writes Stan Bernard ... Read more
